Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
Journal
Clinical Cancer Research
Journal Volume
28
Journal Issue
11
Pages
2286-2296
Date Issued
2022
Author(s)
Majem M.
Goldman J.W.
John T.
Grohe C.
Laktionov K.
Kim S.-W.
Kato T.
Vu H.V.
Lu S.
Li S.
Lee K.Y.
Akewanlop C.
de Marinis F.
Bonanno L.
Domine M.
Shepherd F.A.
Atagi S.
Zeng L.
Kulkarni D.
Medic N.
Tsuboi M.
Herbst R.S.
Wu Y.-L.
SDGs
Publisher
American Association for Cancer Research Inc.
Type
journal article